Clinical Daily News - McKnight's Long Term Care News

Clinical Daily News

Clinical briefs for Thursday, June 17

Chatbots for dementia still in their infancy, tech researchers find … What to know about new Alzheimer’s drug Aduhelm, from scientist who led the trials … Advocacy group urges OIG to investigate FDA’s approval of new Alzheimer’s drug … First patient receives controversial Biogen Alzheimer’s drug at hospital … LTC care needs will double by 2065 … FDA approves Novartis’ drug for aggressive prostate cancer following positive trial results

Clinical briefs for Wednesday, June 16

NIH spotlights promising nasal spray antibody treatment for COVID … Anticoagulation therapy linked to lower COVID death rates: study … Spurned LTC pharmacies push again to receive Provider Relief Funds … Nearly all U.S. doctors fully vaccinated: AMA … Common cold combats COVID, Yale researchers find … Feds find evidence of five more states with COVID cases in December 2019

Clinical briefs for Tuesday, June 15

CMS issues reprieve for 2,500 nursing homes yet to report COVID vaccination rates … Former CMS administrator says nursing homes will remain key test sites for COVID therapies, other treatments … Philips recalls CPAP machines over cancer concerns … Gene treatment could slow Alzheimer’s without targeting brain plaques, new study shows … Jury trial set for maker of Alzheimer’s drug Namenda; company allegedly kept generic off the market

Clinical briefs for Monday, June 14

3 FDA advisory panel members resign in wake of controversial approval of new Alzheimer’s drug … U.S. suspends COVID J&J vaccine shipments as backlog builds; extends expiration dates … VoiceFriend adds new discharged patient module for post-acute care … Computerized tests show how poorly fitting N95 masks increase risk of infection … FDA recalls unapproved COVID test that used falsified data … Parkinson’s drug candidates to be targeted to genetic groups in new Abbie biopharma collaboration
Next post in Clinical Daily News